Ray Takigiku, Ph.D.
President and CEO
Ray Takigiku, PhD is the founder of Bexion Pharmaceuticals, an oncology-focused company with a novel compound in clinical development for solid tumors, including DIPG/DMG a rare brain tumor. Ray is an entrepreneurial life scientist with over 30 years of experience in the discovery, development, and market support of innovative pharmaceuticals. At P&G Pharmaceuticals, Ray was on the leadership team behind the blockbuster Actonel. After leaving P&G, Ray joined SIDIS Global, an investment and management firm creating cutting edge bio-instrumentation and next generation medical devices.